SVB Wealth’s Revolution Medicines RVMD Stock Holding History

SVB Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-65	Closed	-$2.3K	–	1397
2025 Q1	$2.3K	Buy	+65	New	+$2.64K	﹤0.01%	1205

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SVB Wealth's RVMD Position: Q2 2025 in Review

SVB Wealth sold out of Revolution Medicines (RVMD) in Q2 2025, closing a stake of 65 shares — an estimated $2.3K sold.

SVB Wealth first reported a position in RVMD in Q1 2025 and held it in 1 quarter. The position peaked at $2.3K in Q1 2025. 307 funds tracked by Wall St. Rank hold RVMD as of Q2 2025.

SVB Wealth reported no remaining Revolution Medicines position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 65 Revolution Medicines shares in Q2 2025, an estimated $2.3K.
SVB Wealth first reported a position in Revolution Medicines in Q1 2025 and held it in 1 quarter.
SVB Wealth's Revolution Medicines position peaked at $2.3K in Q1 2025.
307 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.